Statistics
Publications
92
Citations
15.1K
H-Index
37
Active since
1983
Shuji Murakami is an author at Kanagawa Prefectural Hospital Organization specializing in medicine, oncology, and lung cancer.
Publications per year
1983–2025
92
92
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text
Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text
Medicine, Oncology, Pharmacology +15
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
1–5 of 92